Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)

CNY 13.28

(0.23%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 16.64 Billion 16.17 Billion 14.33 Billion 9.32 Billion 7.96 Billion 7.35 Billion
Total Current Assets 9.89 Billion 9.45 Billion 7.69 Billion 6.71 Billion 5.6 Billion 5.05 Billion
Cash And Short Term Investments 3.89 Billion 3.51 Billion 2.53 Billion 1.62 Billion 1.45 Billion 1.35 Billion
Cash and Cash Equivalents 3.67 Billion 3.51 Billion 2.23 Billion 1.62 Billion 1.45 Billion 1.35 Billion
Short Term Investments 219.65 Million 8.35 Million 297.3 Million -552.07 Million -493.86 Million 80.99 Million
Net Receivables 1.99 Billion 2.41 Billion 1.77 Billion 1.42 Billion 1.16 Billion 1.19 Billion
Inventory 3.85 Billion 3.38 Billion 3.31 Billion 2.19 Billion 2.02 Billion 1.86 Billion
Other Current Assets 153.33 Million 139.24 Million 65.49 Million 1.47 Billion 959.34 Million 646.92 Million
Total Non-Current Assets 6.75 Billion 6.72 Billion 6.64 Billion 2.61 Billion 2.35 Billion 2.29 Billion
Net PPE 3.99 Billion 3.99 Billion 4.07 Billion 690.51 Million 585.57 Million 535.62 Million
Good Will And Intangible Assets 1.83 Billion 1.56 Billion 1.5 Billion 1.22 Billion 1.15 Billion 1.16 Billion
Good Will 1.64 Billion 1.39 Billion 1.37 Billion 1.1 Billion 1.06 Billion 1.07 Billion
Intangible Assets 184.1 Million 165.67 Million 122.89 Million 122.88 Million 90.51 Million 84.68 Million
Long-Term Investments 165.34 Million 131.44 Million -190.08 Million 635.71 Million 577.4 Million 2.00
Tax Assets 88.94 Million 94.1 Million 58.46 Million 27.61 Million 22.35 Million 28.94 Million
Other Non Current Assets 670.84 Million 939.5 Million 1.19 Billion 31.35 Million 18.07 Million 572.64 Million
Other Assets 1.00 1.00 - 1.00 - 1.00
Total Liabilities 8.75 Billion 8.65 Billion 7.66 Billion 3.54 Billion 3.36 Billion 3.3 Billion
Total Current Liabilities 7.19 Billion 6.87 Billion 5.88 Billion 3.53 Billion 2.82 Billion 3.28 Billion
Account Payables 2.56 Billion 4.32 Billion 3.8 Billion 2.87 Billion 2.31 Billion 2.03 Billion
Tax Payables 81.37 Million 250.37 Million 164.09 Million 105.78 Million 129.27 Million 158.09 Million
Short Term Debt 3.33 Billion 1.33 Billion 1.14 Billion 60.05 Million 16.79 Thousand 798.89 Million
Deferred Revenue 113.72 Million 156.61 Million 921.34 Million 587.58 Million 436.23 Million 1.00
Other Current Liabilities 1.19 Billion 1.05 Billion 12.7 Million 8.59 Million 74.13 Million 458.32 Million
Total Non Current Liabilities 1.55 Billion 1.77 Billion 1.78 Billion 15.78 Million 540.16 Million 17.2 Million
Long-Term Debt 1.55 Billion 1.75 Billion 1.76 Billion 1.79 Billion 482.81 Million 19.66 Thousand
Deferred Revenue Non Current 1.24 Million 12.15 Million 13.33 Million 15.78 Million 39.18 Million 17.18 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 1.00 1.00 -1.79 Billion 1.00 1.00
Other Liabilities 1.00 1.00 - - - -
Total Equity 7.87 Billion 7.52 Billion 6.67 Billion 5.78 Billion 4.59 Billion 4.04 Billion
Stock Holders Equity 7.74 Billion 7.42 Billion 6.57 Billion 5.76 Billion 4.59 Billion 4.04 Billion
Common Stock 596 Million 596.02 Million 596.18 Million 595.31 Million 567.77 Million 567.76 Million
Retained Earnings 4.64 Billion 4.33 Billion 3.5 Billion 2.83 Billion 2.26 Billion 1.87 Billion
Accumulated other comprehensive income 377.8 Million 424.89 Million 405.58 Million 279.75 Million 356.56 Million 198.67 Million
Common Stock Equity 7.74 Billion 7.42 Billion 6.57 Billion 5.76 Billion 4.59 Billion 4.04 Billion
Capital Lease Obligation 1.55 Billion 1.75 Billion 1.72 Billion 1.79 Billion 16.79 Thousand 19.66 Thousand
Total Investments 384.99 Million 139.79 Million 107.21 Million 83.63 Million 83.54 Million 80.99 Million
Total Debt 4.88 Billion 3.09 Billion 2.9 Billion 60.05 Million 482.83 Million 798.89 Million
Net Debt 1.21 Billion -417.58 Million 672.88 Million -1.56 Billion -976.71 Million -552.95 Million

Balance Sheet Charts